MoneyWorks4Me

Neuland Laboratories - Quaterly Results

01 Feb 2022 Evaluate
A slight decline in the revenue of Rs. 2364.70 millions was seen for the December 2021 quarter as against Rs. 2453.92 millions during year-ago period.Profit after Tax for the quarter ended December 2021 saw a decline of -52.27% from Rs. 266.73 millions to Rs. 127.31  millions.A decline of 341.94 millions was observed in the OP in the quarter ended December 2021 from 467.05 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 2364.70 2453.92 -3.64 6952.05 6922.09 0.43 9369.13 7627.11 22.84
Other Income 19.00 1.95 874.36 42.43 14.98 183.24 160.95 38.86 314.18
PBIDT 341.94 467.05 -26.79 1049.27 1225.04 -14.35 1625.39 1053.44 54.29
Interest 33.22 44.39 -25.16 107.25 133.20 -19.48 178.98 215.71 -17.03
PBDT 308.72 422.66 -26.96 942.02 1091.84 -13.72 1446.41 837.73 72.66
Depreciation 127.75 104.07 22.75 365.85 285.37 28.20 396.79 312.76 26.87
PBT 180.97 318.59 -43.20 576.17 806.47 -28.56 1049.62 524.97 99.94
TAX 53.66 51.86 3.47 159.12 175.78 -9.48 246.67 366.16 -32.63
Deferred Tax 9.23 8.83 4.53 25.20 97.96 -74.28 121.84 366.16 -66.72
PAT 127.31 266.73 -52.27 417.05 630.69 -33.87 802.95 158.81 405.60
Equity 129.01 129.01 0.00 129.01 129.01 0.00 129.01 129.01 0.00
PBIDTM(%) 14.46 19.03 -24.02 15.09 17.70 -14.72 17.35 13.81 25.61
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..